Postmortem Findings in Suicide Victims. Implications for in Vivo Imaging Studiesa
Corresponding Author
VICTORIA ARANGO
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Address correspondence to Victoria Arango, Ph.D., Department of Neuroscience, New York State Psychiatric Institute, 722 West 168th St., Box 28, New York, NY 10032, USA. Tel: (212) 960–2440: fax: (212) 781–0503; e-mail: [email protected]Search for more papers by this authorMARK D. UNDERWOOD
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Search for more papers by this authorJ. JOHN MANN
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Search for more papers by this authorCorresponding Author
VICTORIA ARANGO
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Address correspondence to Victoria Arango, Ph.D., Department of Neuroscience, New York State Psychiatric Institute, 722 West 168th St., Box 28, New York, NY 10032, USA. Tel: (212) 960–2440: fax: (212) 781–0503; e-mail: [email protected]Search for more papers by this authorMARK D. UNDERWOOD
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Search for more papers by this authorJ. JOHN MANN
Department of Neuroscience, and the NIMH Clinical Research Center for the Study of Suicidal Behavior, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians & Surgeons of Columbia University, New York, New York 10032, USA
Search for more papers by this authorThis work was supported by NIAAA Grant AA09004 and NIMH Grants MH40210, MH46745, and MH47097
Abstract
Abstract Alterations in serotonergic and noradrenergic receptor binding in membrane homogenates from the brain of suicide victims suggest a biological substrate for the vulnerability to commit suicide. We and others have employed high-resolution quantitative autoradiography of full coronal sections of the prefrontal cortex to map the locus of maximal change in receptor binding. We found alternations in binding to the serotonin transporter, the 5-HT1A', and the 5-HT2A receptors primarily in the ventral and ventrolateral prefrontal cortex of suicide victims. Importantly, these changes are often modest in magnitude and anatomically restricted to one or two Brodmann areas. Furthermore, we have found that care in case selection is essential, because sex, age, drugs, and comorbid diagnoses contribute to receptor binding. The implications for in vivo imaging are considerable, directing the focus of such studies toward the ventrolateral prefrontal cortex. However, because ligands are limited, as is the resolution of current methods, including PET, automated analyses that produce statistical images, rather than manual selection of individual slices, will likely lack the ability to detect the discrete receptor changes found postmortem. Alternatively, the advantages of examining large numbers of subjects, imaging the entire brain, obtaining detailed clinical information in the living patient, and magnifying the changes with neuropharmacological challenges present a promising outlook for making major advances into the identification of brain abnormalities associated with suicide risk.
REFERENCES
- 1
Center For Disease Control And Prevention. 1993. Advance report of final mortality statistics, 1990.
Monthly Vital Statistics Report
41: 1–52.
- 2
Beck, A.T.,
R.A. Kovacs,
M. Steer, &
B. Garrison. 1985. Hopelessness and eventual suicide: A 10-year prospective study of patients hospitalized with suicidal ideation.
Am. J. Psychiatry
142(5): 559–563.
- 3
Mann, J.J. &
V. Arango. 1992. Integration of neurobiology and psychopathology in a unified model of suicidal behavior.
J. Clin. Psychopharmacol.
12(2): 2S–7S.
- 4
Roy, A.
1983. Family history of suicide.
Arch. Gen. Psychiatry
40: 971–974.
- 5
ÅGren, H.
1980. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid II.
Suicide. Psychiatry Res.
3: 225–236.
- 6
ÅSberg, M.,
L. Tråskman &
P. Thorén. 1976. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor
Arch. Gen. Psychiatry
33: 1193–1197.
- 7
Beskow, J.,
C.G. Gottfries,
B.E. Roos &
B. Winblad. 1976. Determination of monoamine and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group.
Acta Psychiatr. Scand.
53: 7–20.
- 8
Bourne, H.R.,
W.E. Bunney, Jr.,
R.W. Colburn,
J.M. Davis,
D.M. Shaw &
A.J. Coppen. 1968. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.
Lancet
ii: 805–808.
- 9
Brown, G.L.,
F.K. Goodwin &
W.E. Bunney, Jr.
1982. Human aggression and suicide: Their relationship to neuropsychiatric diagnoses and serotonin metabolism.
Adv. Biochem. Psychopharmacol.
34: 287–307.
- 10
Lloyd, K.G.,
I.J. Farley,
J.H.N. Deck &
O. Hornykiewicz. 1974. Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brain stem of suicide victims and control patients.
Adv. Biochem. Psychopharmacol.
11: 387–397.
- 11
Pare, C.M.B.,
D.P.H. Yeung,
K. Price &
R.S. Stacey. 1969. 5-Hydroxytryptamine, noradrenaline, and dopamine in brain stem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.
Lancet
ii: 133–135.
- 12
Shaw, D.M.,
F.E. Camps &
E.G. Eccleston. 1967. 5-Hydroxytryptamine in the hind-brain of depressive suicides.
Br. J. Psychiatry
113: 1407–1411.
- 13
Malone, K.M.,
E.M. Corbitt,
S. Li &
J.J. Mann. 1996. Prolactin response to fenfluramine and suicide attempt lethality in major depression.
Br. J. Psychiatry
168: 324–329.
- 14
Mann, J.J. &
K.M. Malone. 1997. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients.
Biol. Psychiatry
41: 162–171.
- 15
Mann, J.J.,
K.M. Malone,
J.A. Sweeney,
R.P. Brown,
M. Linnoila,
B. Stanley &
M. Stanley. 1996. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.
Neuropsychopharmacology
15: 576–586.
- 16
J.J. Mann &
M. Stanley, Eds.
1986. Psychobiology of Suicidal Behavior. The New York Academy of Sciences,
New York
,
NY
pp.
1–355.
- 17
Mann, J.J.,
V. Arango,
P.M. Marzuk,
S. Theccanat &
D.J. Reis. 1989. Evidence for the 5-HT hypothesis of suicide: A review of post-mortem studies.
Br. J. Psychiatry
155 (Suppl. 8): 7–14.
- 18
Arango, V.,
M.D. Underwood,
A.V. Gubbi &
J.J. Mann. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.
Brain Res.
688: 121–133.
- 19
Van Dop, C. &
H.R. Bourine. 1983. Pseudohypoparathyroidism.
Annu. Rev. Med.
34: 259–266.
- 20
Cochran, E.,
E. Robins &
S. Grote. 1976. Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls.
Biol. Psychiatry
11: 283–294.
- 21
Korpi, E.R.,
J. Kleinman,
S.I. Goodman,
I. Phillips,
L.E. Delisi,
M. Linnoila &
R.J. Wyatt. 1986. Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death.
Arch. Gen. Psychiatry
43: 594–600.
- 22
Owen, F.,
D.R. Chambers,
S.J. Cooper,
T.J. Crow,
J.A. Johnson,
R. Lofthouse &
M. Poulter. 1986. Serotonergic mechanisms in brains of suicide victims.
Brain Res.
362: 185–188.
- 23
Cheetham, S.C.,
M.R. Crompton,
C. Czudek,
R.W. Horton,
C.L.E. Katona &
G.P. Reynolds. 1989. Serotonin concentrations and turnover in brains of depressed suicides.
Brain Res.
502: 332–340.
- 24
Crow, T.J.,
A.J. Cross,
S.J. Cooper,
J.F.W. Deakin,
I.N. Ferrier,
J.A. Johnson,
M.H. Joseph,
F. Owen,
M. Poulter,
R. Lofthouse,
J.A.N. Corsellis,
D.R. Chambers,
G. Blessed,
E.K. Perry,
R.H. Perry &
B.E. Tomlinson. 1984. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
Neuropharmacology
23: 1561–1569.
- 25
Owen, F.,
A.J. Cross,
T.J. Crow,
J.F.W. Deakin,
I.N. Ferrier,
R. Lofthouse &
M. Poulter. 1983. Brain 5-HT2 receptors and suicide.
Lancet
ii: 1256.
- 26
Palmer, A.M.,
S.L. Lowe,
P.T. Francis &
D.M. Bowen. 1988. Are post-mortem biochemical studies of human brain worthwhile.
Biochem. Soc. Trans.
16: 472–475.
- 27
Reis, D.J.,
M. Weinbren &
A. Corvelli. 1968. A circadian rhythm of norepinephrine regionally in cat brain: its relationship to environmental lighting and to regional diurnal variations in brain serotonin.
J. Pharmacol. Exp. Ther.
164: 135–145.
- 28
Reis, D.J.,
A. Corvelli &
J. Conners. 1969. Circadian and ultradian rhythms of serotonin regionally in cat brain.
J. Pharmacol. Exp. Ther.
167: 328–333.
- 29
Spokes, E.G.S.
1979. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.
Brain
102: 333–346.
- 30
Carlsson, A.,
R. Adolfsson,
S.M. Aquilonius,
C.G. Gottfries,
L. Oreland,
L. Svennerholm &
B. Winblad. 1980. Biogenic amines in human brain in normal aging, senile dementia and chronic alcoholism. In
Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects. M. Goldstein, Ed:. 295–304. Raven Press.
New York
.
- 31
Carlsson, A.,
L. Svennerholm &
B. Winblad. 1980. Seasonal and circadian monoamine variations in human brains examined post mortem.
Acta Psychiatr. Scand.
280 (Suppl.): 75–85.
- 32
Bucht, G.,
R. Adolfsson,
C.G. Gottfries,
B.-E. Roos &
B. Winblad. 1981. Distribution of 5-Hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.
J. Neural Transm.
51: 185–203.
- 33
Karson, C.N.,
K.F. Berman,
J. Kleinman &
F. Karoum. 1984. Seasonal variation in human central dopamine activity.
Psychiatry Res.
11: 111–117.
- 34
Mann, J.J.,
C. Petito,
M. Stanley,
P.A. Mcbride,
J. Chin &
A. Philogene. 1985. Amine receptor binding and monoamine oxidase activity in postmortem human brain tissue: Effect of age, gender and postmortem delay. In
Clinical and Pharmacological Studies in Psychiatric Disorders. G.D. Burrows,
T.R. Norman &
L. Dennerstein Eds:. 37–39. John Libbey & Co. Ltd.
London
.
- 35
Wirz-Justice, A.
1987. Circadian rhythms in mammalian neurotransmitter receptors.
Prog. Neurobiol.
29: 219–259.
- 36
Ferraro, J.S. &
R.W. Steger. 1990. Diurnal variations in brain serotonin are driven by the photic cycle and are not circadian in nature.
Brain Res.
512: 121–124.
- 37
Diksic, M.
1992. Alpha-methyl tryptophan as a tracer for in vivo studies of brain serotonin system, from autoradiography to positron emission tomography.
J. Chem. Neuroanat.
5: 349–354.
- 38
Cohen, Z.,
K. Tsuiki,
A. Takada,
A. Beaudet,
M. Diksic &
E. Hamel. 1995. In vivo synthesized radioactively labelled α-methyl serotonin as a selective tracer for visualization of brain serotonin neurons.
Synapse
21: 21–28.
- 39
Soucy, J.-P.,
F. Lafaille,
P. Lemoine,
A. Mrini &
L. Descarries. 1994. Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in brain.
J. Nucl. Med.
35: 1822–1830.
- 40
Hrdina, P.D.
1984. Differentiation of two components of specific [3H]imipramine binding in rat brain.
Eur. J. Pharmacol.
102: 481–488.
- 41
Cash, R.,
R. Raisman,
A. Ploska &
Y. Agid. 1985. High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains.
Eur. J. Pharmacol.
117: 71–80.
- 42
D'Amato, R.J.,
B.L. Largent,
A.M. Snowman &
S.H. Snyder. 1987. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
J. Pharmacol. Exp. Ther.
242: 364–371.
- 43
Marcusson, J.O. &
S.B. Ross. 1990. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
Psychopharmacol. Ser. (Berlin)
102: 145–155.
- 44
Dumbrille-Ross, A. &
S.W. Tang. 1983. Binding of [3H]Ro 11–2465. Possible identification of a subclass of [3H]imipramine binding sites.
Mol. Pharmacol.
23: 607–613.
- 45
Kovachich, G.B.,
C.E. Aronson,
D.J. Brunswick &
A. Frazer. 1988. Quantitative autoradiography of serotonin uptake sites in rat brain using 3H-cyanoimipramine.
Brain Res.
454: 78–88.
- 46
Mann, J.J.,
R.A. Henteleff,
T.F. Lagattuta,
J.A. Perper,
S. Li &
V. Arango. 1996. Lower 3H-Paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high-affinity, non-transporter sites.
J. Neural Transm.
103: 1337–1350.
- 47
Andersson, A.,
A. Eriksson &
J. Marcusson. 1992. Unaltered number of brain serotonin uptake sites in suicide victims.
J. Psychopharmacol.
6: 509–513.
- 48
Hrdina, P.D.,
E. Demeter,
T.B. Vu,
P. Sotonyi &
M. Palkovits. 1993. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant- free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala.
Brain Res.
614: 37–44.
- 49
Bäckström, I.,
M. Bergström &
J. Marcusson. 1989. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
Brain Res.
486: 261–268.
- 50
Arango, V. &
J.J. Mann. 1992. Relevance of serotonergic postmortem studies to suicidal behavior.
Int. Rev. Psychiatry
4: 131–140.
- 51
Mann, J.J.,
M.D. Underwood &
V. Arango. 1996. Postmortem studies of suicide victims. In
Biology of Schizophrenia and Affective Disease, S.J. Watson, Ed:. 197–220. American Psychiatric Press, Inc.
Washington
,
DC
.
- 52
Mann, J.J.,
M.D. Underwood &
V. Arango. 1995. Brain serotonergic abnormalities in the prefrontal cortex in depression and suicide. 2nd International Conference on New Directions in Affective Disorders. Jerusalem, Israel.
- 53
Paul, S.M.,
M. Rehavi,
P. Skolnick &
F.K. Goodwin. 1984. High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet; studies in depression. In
Neurobiology of Mood Disorders. R.M. Post &
C.J. Bellinger, Eds:. 846–853. Williams and Wilkins.
Baltimore
.
- 54
Lawrence, K.M.,
F. De Paermentier,
S.C. Cheetham,
M.R. Crompton,
C.L.E. Katona &
R.W. Horton. 1990. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides.
Brain Res.
526: 17–22.
- 55
Arato, M.,
K. Tekes,
M. Palkovits,
E. Demeter &
A. Falus. 1987. Serotonergic split brain and suicide.
Psychiatry Res.
21: 355–356.
- 56
Arato, M.,
K. Tekes,
L. Tothfalusi,
K. Magyar,
M. Palkovits,
E. Frecska,
A. Falus &
D.J. Maccrimmon. 1991. Reversed hemispheric asymmetry of imipramine binding in suicide victims.
Biol. Psychiatry
29: 699–702.
- 57
Lawrence, K.M.,
F. De Paermentier,
S.C. Cheetham,
M.R. Crompton,
C.L.E. Katona &
R.W. Horton. 1990. Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicides.
Biol. Psychiatry
28: 544–546.
- 58
Gross-Isseroff, R.,
M. Isiraeli &
A. Biegon. 1989. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide.
Arch. Gen. Psychiatry
46: 237–241.
- 59
Arango, V.,
P. Ernsberger,
P.M. Marzuk,
J.-S. Chen,
H. Tierney,
M. Stanley,
D.J. Reis &
J.J. MANN. 1990. Autoradiographic demonstration of increased serotonin 5-HT2 and ß-adrenergic receptor binding sites in the brain of suicide victims.
Arch. Gen. Psychiatry
47: 1038–1047.
- 60
Mann, J.J.,
M. Stanley,
P.A. Mcbride &
B.S. Mcewen. 1986. Increased serotonin2 and ß-adrenergic receptor binding in the frontal cortices of suicide victims.
Arch. Gen. Psychiatry
43: 954–959.
- 61
Stanley, M. &
J.J. Mann. 1983. Increased serotonin-2 binding sites in frontal cortex of suicide victims.
Lancet
i: 214–216.
- 62
Gross-Isseroff, R.,
D. Salama,
M. Israeli &
A. Biegon. 1990. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: Effect of suicide.
Brain Res.
507: 208–215.
- 63
Takahashi, R.,
T. Tateishi,
H. Yoshida &
I. Hironaka. 1982. Effects of chronic treatment with antidepressant drugs on serotonergic receptor binding activity in normal and tetrabenazine depression rat. In
New Vistas in Depression, S. Langer,
R. Takahashi,
T. Segawa &
M. Briley, Eds:. 29–36. Pergamon Press.
New York
.
- 64
Stockmeier, C.A. &
K.J. Kellar. 1986. In vivo regulation of serotonin-2 receptor in rat brain.
Life Sci.
38: 117–127.
- 65
Roth, B.L.,
S. Mclean,
X.-Z. Zhu &
D.-M. Chuang. 1987. Characterization of two [3H]ketanserin recognition sites in rat striatum.
J. Neurochem.
49: 1833–1838.
- 66
Matsubara, S.,
R.C. Arora &
H.Y. Meltzer. 1991. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.
J. Neural Transm.
85: 181–194.
- 67
Yates, M. &
I.N. Ferrier. 1990. 5-HT1A receptors in major depression.
J. Psychopharmacol.
4: 69–74.
- 68
Arranz, B.,
A. Eriksson,
E. Mellerup,
P. Plenge &
J. Marcusson. 1994. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims.
Biol. Psychiatry
35: 457–463.
- 69
Gass, P.,
M. Spranger &
M. Kiessling. 1993. Induction of early-response genes after focal ischemia.
Cerebrovasc. Dis.
3: 74–79.
- 70
Tork, I.,
G.M. Halliday &
R.G.H. Cotton. 1992. Application of antiphenylalanine hydroxylase antibodies to the study of the serotonergic system in the human brain.
J. Chem. Neuroanat.
3: 311–313.
- 71
Huang, Y.,
R. Grailhe,
M. Zhou,
R. Hen,
V.D. Khait,
V. Arango &
J.J. Mann. 1996. Suicide and the human 5-HT1Dß receptor and gene.
Soc. Neurosci. Abstr.
22: 730.
- 72
Mann, J.J.,
V. Arango,
R.A. Henteleff,
T.F. Lagattuta &
D.T. Wong. 1996. Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal.
J. Neural Transm.
103: 165–171.
- 73
Henteleff, R.A.,
V. Arango &
J.J. Mann. 1992. Serotonin 5-HT2 but not 5-HT1C receptor number is increased in the hippocampus of suicide victims.
Soc. Neurosci. Abstr.
18: 1598.
- 74
Rajkowska, G. &
P.S. Goldman-Rakic. 1995. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria.
Cereb. Cortex
5: 307–322.
- 75
Martin, P.R.,
H. Weingartner,
E.K. Gordon,
R.S. Burns,
M. Linnoila,
I.J. Kopin &
M.H. Ebert. 1984. Central nervous system catecholamine metabolism in Korsakoff's psychosis.
Ann. Neurol.
15: 184–187.
- 76
Rajkowska, G. &
P.S. Goldman-Rakic. 1995. Cytoarchiteconic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the talairach coordinate system.
Cereb. Cortex
5: 323–337.
- 77
Mann, J.J.,
K.M. Malone,
D.J. Diehl,
J. Perel,
T.B. Cooper &
M.A. Mintun. 1996. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
Am. J. Psychiatry
153: 174–182.